Wearable cardioverter-defibrillator use in clinical settings in Poland: Nationwide observational cohort studyMaciej Sterliński, Jerzy Krzysztof Wranicz, Zofia Dzielińska et al.|Kardiologia Polska|2025Cited by 5
High-Power Short-Duration Radiofrequency Ablation of Atrial FibrillationAdam Wojtaszczyk, Paweł Ptaszyński, Krzysztof Kaczmarek|Lecture notes in bioengineering|2022Cited by 1
Cost-utility analysis of the use of a wearable cardioverter defibrillator (LifeVest®) versus standard of care in the prevention of sudden cardiac death in patients after myocardial infarctionPrzemysław Mitkowski, Dominik Golicki, Maciej Sterliński et al.|Kardiologia Polska|2025Cited by 1
Pulsed field ablation – new perspective in atrial fibrillation therapyAdam Wojtaszczyk, Krzysztof Kaczmarek, Paweł Ptaszyński|In a good rythm|2021Cited by 0
Dependence from cardiac contractility modulation -- a loss of modulation as a cause of heart failure exacerbation.Adam Wojtaszczyk, Iwona Cygankiewicz, Krzysztof Kaczmarek et al.|Unknown|2024Cited by 0